Tirzepatide
Dual incretin receptor agonist (GLP-1 + GIP) for advanced metabolic pathway research
Volume pricing
Per-kit price drops as you scaleAdd 1 more kit
Unlock Lab pricing at $185/kit
extra savings
Free Worldwide Shipping
No minimum order. Customs handled.
Express Delivery
7-14 Days
Ships To
190+ Countries
Customs Handled
99% Success Rate
Stealth Packaging
Cold-Chain
Lab-Grade Guarantee
If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.
99.27% Purity Verified
HPLC / ESI-MS Tested
FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.
Tirzepatide: Key Facts
Tirzepatide is a weight loss research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 13 formats starting at $280 per kit. Each batch is independently HPLC-verified at 99.27% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.
| Compound | Tirzepatide |
|---|---|
| Research category | Weight Loss |
| Available formats | 5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 50mg*10vials, 60mg*10vials, 70mg*10vials, 80mg*10vials, 90mg*10vials, 100mg*10vials, 120mg*10vials |
| Starting price | From $280 USD per kit |
| Purity | 99.27% verified (third-party HPLC, Janoshik) |
| Test method | HPLC / ESI-MS |
| Certificate of analysis | Published online, matched to the vial lot number |
| Intended use | Laboratory research use only. Not for human consumption. |
| Handling | Supplied lyophilized, store per the stability guide |
Dr. Anjali Verma
Singapore
"Our diabetes research lab at a clinical research team in Chandigarh has been using Tirzepatide for dual incretin studies for 7 months. The dual receptor activation profile is consistent across batches - we've confirmed this with both GLP-1 and GIP receptor binding assays. The comprehensive dosage range from 5mg to 120mg is ideal for extensive metabolic research."
2025-11-12
Dr. Halvorsen
United States
"No issues across two orders. Fast comms, honest specs."
2025-11-09
T. Fischer
Italy
"Everything as described. The lot-matched certificate is what keeps me here."
2025-11-06
About This Product
Tirzepatide Research Guide
The Dual Agonist That Raised the Ceiling
Tirzepatide is a dual agonist of the GLP-1 and GIP receptors, the first compound to combine these two incretin pathways in a single molecule. The research community sometimes calls it a twincretin, which is accurate in the sense that it engages both major incretin receptors, but the real story is how the two signals amplify each other when they fire simultaneously on the same pancreatic beta cells.
In matched research protocols against Semaglutide, Tirzepatide consistently produces larger metabolic effects with improved dose tolerability. The GIP component is the reason.
Why GIP Changes Everything
For years GIP was thought to be unimportant for metabolic research because activation alone did not produce reproducible metabolic effects in research models. Modern work reversed that view entirely. Combined with GLP-1 activation, GIP receptor agonism amplifies insulin secretion synergistically (not additively), improves lipid handling, modulates lipid distribution research outcomes, and buffers the nausea that caps dose escalation on pure GLP-1 compounds.
That nausea buffering is what lets Tirzepatide reach higher effective doses than Semaglutide can tolerate in matched research cohorts. It is not that Tirzepatide is stronger per milligram. It is that the GIP piece lets you use more of it before tolerability becomes the limiting variable.
Research Applications
- Dual-incretin pharmacology and receptor crosstalk studies
- Protocols requiring higher-potency GLP-1 axis activation than Semaglutide tolerates
- Comparative metabolic research against single-agonist and triple-agonist baselines
- Lipid handling research where the GIP component is the mechanism of interest
- Replication and extension of dual-agonist research protocols
Quality Standards
- Purity: 99 percent plus verified by independent third-party HPLC (Janoshik Analytical)
- Mass Spec Confirmation: within tolerance of the expected Tirzepatide molecular weight
- Form: lyophilized powder in sterile vials
- Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
- Documentation: batch-matched Certificate of Analysis published at /lab-results
For the mechanism breakdown and the comparison against single and triple agonists, see the [Tirzepatide Dual Agonist Research Guide](/blog/tirzepatide-dual-agonist-research-guide) and [Retatrutide vs Tirzepatide vs Semaglutide](/blog/retatrutide-vs-tirzepatide-vs-semaglutide).
For research purposes only. Not for human consumption or therapeutic use.
Research Context for Tirzepatide
Metabolic and Weight Loss Research Context
This compound sits in the incretin and metabolic peptide class, where research focuses on appetite regulation, glucose handling, energy expenditure, and the complex signaling network that connects gut, pancreas, liver, and hypothalamus. Research protocols in this category typically involve dose escalation, tolerability mapping, and long-duration observation of metabolic endpoints.
Tirzepatide ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Weight Loss category, with 13 variant options sized to different research protocols. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.
Related Research Guides
Retatrutide vs Tirzepatide vs Semaglutide
Full receptor-level comparison of the three leading metabolic peptides with a decision framework for research protocols.
Tirzepatide Dual Agonist Research Guide
Why Tirzepatide is called Ozempic on steroids and what GIP adds to the GLP-1 foundation in research models.
How to Read a Peptide Certificate of Analysis
The verification routine every research lab should run before accepting a vial.
Other Compounds in the Weight Loss Category
Frequently Asked Questions
Tirzepatide
$280